Here we have studied the biochemical and clinical consequences of PAPSS2 deficiency in a family with two brothers compound heterozygous for two novel PAPSS2 mutations, who presented with clinically overt SEMD, low serum DHEAS, but normal serum androgens. The gene discussed is PAPSS2; the disease is spondyloepimetaphyseal dysplasia.